High-Content Drug Discovery Targeting Molecular Bladder Cancer Subtypes

Molecular subtypes of muscle-invasive bladder cancer (MIBC) display differential survival and drug sensitivities in clinical trials. To date, they have not been used as a paradigm for phenotypic drug discovery. This study aimed to discover novel subtype-stratified therapy approaches based on high-co...

Descripción completa

Detalles Bibliográficos
Autores principales: Rinaldetti, Sébastien, Zhou, Qiong, Abbott, Joshua M., de Jong, Florus C., Esquer, Hector, Costello, James C., Theodorescu, Dan, LaBarbera, Daniel V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9506379/
https://www.ncbi.nlm.nih.gov/pubmed/36142576
http://dx.doi.org/10.3390/ijms231810605

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9506379/
https://www.ncbi.nlm.nih.gov/pubmed/36142576
http://dx.doi.org/10.3390/ijms231810605

Ejemplares similares